MedPath

effects of folic acid combination with fluoxetine in treatment of patients with major depressive disorder under age 18

Phase 3
Recruiting
Conditions
Major depressive disorder, single episode
major depressive disorder.
Registration Number
IRCT20230619058530N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

clinical diagnosis of Major Depressive Disorder according to DSM-5 criteria
consent to participate in the study by completing the informed consent form by patient and patient
Lack of any history of receiving any anti depressant drug or mood stabilizers during recent 3 month before study
lack of history of allergic reaction to drug
age between 6-18 years

Exclusion Criteria

need to ECT treatment during study
any unexpected new physical or mental condition that could change medical care of patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.